Auris Medical Cuts Expected IPO To $56M
Switzerland's Auris Medical Holding AG, which develops treatments for inner ear disorders, slashed its set price range to $6 on Tuesday, cutting the anticipated initial public offering to $56 million as...To view the full article, register now.
Already a subscriber? Click here to view full article